Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Change in Acquisitions & Divestments (2023)

Senti Biosciences (SNTI) has 1 years of Change in Acquisitions & Divestments data on record, last reported at $23.0 million in Q3 2023.

  • For Q3 2023, Change in Acquisitions & Divestments changed N/A year-over-year to $23.0 million; the TTM value through Jun 2024 reached $23.0 million, down 37.84%, while the annual FY2023 figure was $60.0 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments reached $23.0 million in Q3 2023 per SNTI's latest filing, up from $22.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $23.0 million in Q3 2023 and bottomed at $15.0 million in Q1 2023.